Class Author

Leah Frederick
No Attachment

Leah owns the consulting firm Infection Prevention Consultants, LLC, providing infection prevention mentorship and program development services to for-profit and not-for-profit health care providers nationwide.


What People Are Saying...

Clostridium Difficile Colitis Prevention And Management

An online continuing education course for nurses, medical health care professionals, and other interested individuals.

Clostridium difficile is an inimitable organism that normally lives in the gut. When an antibiotic is taken to treat an infection, helpful or normal bacteria are destroyed, causing an overgrowth of the C. difficile bacteria. Clostridium difficile localizes to the large bowel, where it manifests as diarrhea and colitis. The symptoms of CDI can be mild or life-threatening.

Clostridium difficile is the leading cause of infectious diarrhea in hospitals and has become, along with methicillin-resistant Staphylococcus aureus, one of the most common causes of health care–associated infections.¹ The incidence and severity of C. difficile infection (CDI) have increased dramatically since 2000, and CDI is estimated to cause as many as 20,000 deaths and to cost as much as $3.2 billion per year in US acute care facilities alone.² CDI outbreaks have become more common, and infection control–based CDI prevention efforts appear to be less effective than in the past.

How does your facility prevent patients from getting a CDI during their stay? In this course you will learn the characteristics and transmission of CDI, best practices for monitoring these infections, and the recommended practices for prevention and control.

[1] Miller BA, Chen LF, Sexton DJ, Anderson DJ. The impact of hospital-onset healthcare facility associated (HO-HCFA) Clostridium difficile infection (CDI) in community hospitals: surpassing methicillin-resistant Staphylococcus aureus (MRSA) as the new superbug. Paper presented at: 5th Decennial International Conference on Healthcare-Associated Infections, 18–22 March 2010; Atlanta, Georgia.
[2] McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene–variant strain of Clostridium difficile. N Engl J Med 2005;353(23):2433–2441.


  1. Discuss 2 features of the microorganism Clostridium difficile which make transmission difficult to control in the healthcare setting. 
  2. List the elements of a program to recognize and prevent CDI and transmission in the healthcare setting.
  3. Discuss the importance of hand hygiene and environmental cleaning in prevention of transmission of Clostridium difficile.
  4. Describe resources for controlling CDI in the healthcare setting.


Chapter 1: The Organism

A. Case study
B. Media/Public Attention
C. Features
D. Pathogenesis
E. Transmission
Chapter 2: The Disease
A. Symptoms
B. Risk Factors
C. Epidemiology
D. Impact
E. Colonization vs. Infection
F. Diagnosis
G. Treatment Options
Chapter 3: Prevention and Control
A. Core Strategies
B. Outbreak Management (Supplemental Strategies)
Chapter 4: Surveillance
A. Definitions for Surveillance
B. Calculating Rates for Reporting
C. Process Measures
D. Outcome Measures
Chapter 5: Research Needs

Course Snapshot

Cost: $ 45.00
Contact Hours: 1.25


This educational offering has been reviewed by the National Continuing Education Review Service (NCERS) of the National Association of Long Term Care Administrator Boards (NAB) and approved for 1.25 clock hours. Program Approval Number: 1922013-1.25-10485-dl-co
Powered by Kentico CMS